₹ 2.6 Cr
Volume Transacted
(Nov 22, 2024)
28.2 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
Shilpa Medicare Ltd
NSE: SHILPAMED
ISIN
INE790G01031
Last updated on: Nov 23, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Shilpa Medicare Ltd
NSE: SHILPAMED
Share Price
₹ 911
-24.80 (-2.65%)
Last updated on: Nov 22, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 911 | 945 | 954.2 | 901.6 |
21 Nov 2024 | 935.8 | 900.45 | 944 | 864.55 |
19 Nov 2024 | 879.9 | 885.4 | 917.2 | 874.05 |
18 Nov 2024 | 863.4 | 889.2 | 889.2 | 837.25 |
14 Nov 2024 | 872.9 | 830.05 | 894.5 | 816 |
13 Nov 2024 | 824.75 | 895.65 | 895.65 | 814 |
12 Nov 2024 | 878.05 | 895 | 909.45 | 870 |
11 Nov 2024 | 893.2 | 832 | 904.95 | 832 |
08 Nov 2024 | 852.7 | 844 | 875.5 | 817.05 |
07 Nov 2024 | 843.4 | 845 | 872.25 | 829.7 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 911 |
21 Nov 2024 | 935.8 |
19 Nov 2024 | 879.9 |
18 Nov 2024 | 863.4 |
14 Nov 2024 | 872.9 |
13 Nov 2024 | 824.75 |
12 Nov 2024 | 878.05 |
11 Nov 2024 | 893.2 |
08 Nov 2024 | 852.7 |
07 Nov 2024 | 843.4 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 23 Nov 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Shilpa Medicare Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Shilpa Medicare Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Shilpa Medicare spurts on European regulator nod for Octreotide & Nifedipine
Octreotide, a synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid-p...
19 Nov 202411:24
Shilpa Medicare rallies after robust Q2 results
Profit before tax (PBT) surged 300.98% to Rs 36.77 crore in Q2 FY25 over Q2 FY24. EBITDA j...
14 Nov 202410:39
Shilpa Medicare update on its CDMO partner - Unicycive Therapeutics
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has announced that the U.S. Food and Drug Admi...
12 Nov 202415:02
Shilpa Medicare schedules board meeting
Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 13 Novembe...
04 Nov 202418:42
Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility
In a regulatory filing made during market hours today, the company informed the company's ...
31 Oct 202413:43
Shilpa Medicare arm gets CEP from EDQM for Desmopressin
Desmopressin is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid...
04 Oct 202408:40
Unlimited trading at just
Rs. 199*